Microcystin-leucine-arginine causes blood-testis barrier disruption and degradation of occludin mediated by matrix metalloproteinase-8

Cell Mol Life Sci. 2018 Mar;75(6):1117-1132. doi: 10.1007/s00018-017-2687-6. Epub 2017 Oct 25.

Abstract

Microcystin-leucine-arginine (MC-LR) can cause male reproductive disorders. However, the underlying mechanisms are not yet fully understood. In this study, we aimed to investigate the effects of MC-LR on the integrity of blood-testis barrier (BTB) and the related molecular mechanisms. Both transepithelial electrical resistance measurement in vitro and electron microscope observation ex vivo revealed that MC-LR caused disruption of the tight junction between Sertoli cells, which was paralleled by the degradation of occludin. We observed increased expression of matrix metalloproteinase-8 (MMP-8) upon exposure to MC-LR, and confirmed that abrogation of MMP-8 activity by specific inhibitors as well as transfection with MMP-8 shRNA could abolish the degradation of occludin. Our data demonstrated that MC-LR up-regulated nuclear levels of c-Fos and c-Jun through activating ERK and JNK, and increased NF-κB levels by activating the phosphatidylinositol 3-kinase (PI3K)/AKT cascades. Enhanced binding of c-Fos and NF-κB to the promoter of MMP-8 promoted the transcription of MMP-8 gene. Furthermore, miR-184-3p was significantly downregulated in SC following exposure to MC-LR through targeting MMP-8 expression. Together, these results confirmed that MC-LR-induced MMP-8 expression was regulated at both transcriptional and post-transcriptional levels, which was involved in MC-LR-induced degradation of occludin and BTB destruction. This work may provide new perspectives in developing new diagnosis and treatment strategies for MC-induced male infertility.

Keywords: MMP-8; Microcystin–leucine–arginine; Occludin degradation; Transcriptional and post-transcriptional levels.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Toxins / toxicity*
  • Blood-Testis Barrier / drug effects*
  • Blood-Testis Barrier / metabolism
  • Blood-Testis Barrier / ultrastructure
  • Cell Line
  • Gene Expression Regulation / drug effects*
  • Male
  • Matrix Metalloproteinase 8 / genetics*
  • Matrix Metalloproteinase 8 / metabolism
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred ICR
  • MicroRNAs / genetics
  • MicroRNAs / metabolism
  • Microcystins / toxicity*
  • Mitogen-Activated Protein Kinase 1 / genetics
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / genetics
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • NF-kappa B / genetics
  • NF-kappa B / metabolism
  • Occludin / genetics
  • Occludin / metabolism
  • Phosphatidylinositol 3-Kinases / genetics
  • Phosphatidylinositol 3-Kinases / metabolism
  • Primary Cell Culture
  • Proteolysis
  • Proto-Oncogene Proteins c-akt / genetics
  • Proto-Oncogene Proteins c-akt / metabolism
  • Proto-Oncogene Proteins c-fos / genetics
  • Proto-Oncogene Proteins c-fos / metabolism
  • Proto-Oncogene Proteins c-jun / genetics
  • Proto-Oncogene Proteins c-jun / metabolism
  • RNA, Small Interfering / genetics
  • RNA, Small Interfering / metabolism
  • Sertoli Cells / cytology
  • Sertoli Cells / drug effects*
  • Sertoli Cells / metabolism
  • Tight Junctions / drug effects
  • Tight Junctions / metabolism
  • Tight Junctions / ultrastructure

Substances

  • Bacterial Toxins
  • MicroRNAs
  • Microcystins
  • Mirn183 microRNA, mouse
  • NF-kappa B
  • Occludin
  • Ocln protein, mouse
  • Proto-Oncogene Proteins c-fos
  • Proto-Oncogene Proteins c-jun
  • RNA, Small Interfering
  • Phosphatidylinositol 3-Kinases
  • Proto-Oncogene Proteins c-akt
  • Mapk1 protein, mouse
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • MMP8 protein, mouse
  • Matrix Metalloproteinase 8